IGM BIOSCIENCES INC. - COMMON STOCK

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

08 مايو 2024 15:10:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference

07 مايو 2024 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Refocusing of Sanofi Collaboration

17 أبريل 2024 07:30:58 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

10 أبريل 2024 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

07 مارس 2024 15:10:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 يناير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension

05 ديسمبر 2023 15:01:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Third Quarter 2023 Financial Results

13 نوفمبر 2023 15:10:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at Two Upcoming Investor Conferences

07 نوفمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors

03 أكتوبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 سبتمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2023 Financial Results

03 أغسطس 2023 15:10:00 بحسب Nasdaq GlobeNewswire

IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

03 يوليو 2023 15:01:00 بحسب Nasdaq GlobeNewswire

IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement

22 يونيو 2023 06:58:50 بحسب Nasdaq GlobeNewswire

IGM Announces Proposed Public Offering and Concurrent Private Placement

21 يونيو 2023 16:17:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

02 يونيو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies Healthcare Conference

01 يونيو 2023 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis

31 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update

30 مايو 2023 06:00:00 بحسب Nasdaq GlobeNewswire